- Report
- October 2024
- 187 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 207 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- October 2024
- 99 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
The Postpartum Hemorrhage Treatment Device market is a subset of the larger Surgical Devices market. These devices are used to treat postpartum hemorrhage, a condition that occurs when a woman experiences excessive bleeding after childbirth. Postpartum hemorrhage is a leading cause of maternal mortality worldwide. Postpartum Hemorrhage Treatment Devices are designed to reduce the risk of maternal death by controlling the bleeding and restoring blood volume. These devices include uterine balloons, uterine tamponade, and uterine compression sutures. They are used in combination with other treatments such as medications and blood transfusions.
Some companies in the Postpartum Hemorrhage Treatment Device market include Cook Medical, Medtronic, B. Braun, and Stryker. Show Less Read more